4.6 Article

Case report: Rare among ultrarare-Clinical odyssey of a new patient with Ogden syndrome

Journal

FRONTIERS IN GENETICS
Volume 13, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fgene.2022.979377

Keywords

Ogden syndrome; NAA10 gene; progeroid appearance; feeding difficulties; pulmonary infections

Ask authors/readers for more resources

Summary: This article reports the tenth worldwide diagnosed case of Ogden syndrome. It expands the understanding of the morphologic and clinical phenotype, emphasizing the potential severity of pulmonary disorders in these patients, which may pose a greater threat to a child's life than the more commonly described cardiovascular dysfunctions associated with this syndrome.
Introduction: The definition of ultra-rare disease in terms of its prevalence varies between the sources, usually amounting to ca. 1 in 1.000.000 births. Nonetheless, there are even less frequent disorders, such as Ogden syndrome, which up to this day was diagnosed in less than 10 patients worldwide. They present typically with a variety of developmental defects, including postnatal growth retardation, psychomotor delay and hypotonia. This disorder is caused by the heterozygous mutations in NAA10 gene, which encodes N-alpha-acetyltransferase 10, involved in protein biosynthesis. Therefore, Ogden syndrome belongs to the broader group of genetic disorders, collectively described as NAA10-related syndrome.Case report: We present a case of a Polish male infant, born in 39. GW with c-section due to the pathological cardiotocography signal. Hypotrophy (2400 g) and facial dysmorphism were noted in the physical examination. From the first minute, the child required mechanical ventilation - a nasal continuous positive airway pressure. For the first 27 days, the patient was treated in a neonatal intensive care unit, where a series of examinations were conducted. On their basis, the presence of the following defects was determined: muscular ventricular septal defects, patent foramen ovale, pectus excavatum, clubfoot and axial hypotonia. Child was then consequently referred to the genetic clinic for counselling. Results of the tests allowed the diagnosis of Ogden syndrome. In the following months the patient's condition worsened due to the numerous pulmonary infections. Despite the advanced treatment including the variety of medications, the patient eventually died at the age of 10 months.Conclusion: This case report presents a tenth patient diagnosed with Ogden syndrome reported worldwide. It expands the morphologic and clinical phenotype, emphasizing the possible severity of pneumonological disorders in these patients, which may pose a greater threat to a child's life than more frequently described cardiovascular dysfunctions associated with this syndrome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Allergy

Implementation of the web-based calculator estimating odds ratio of severe COVID-19 for unvaccinated individuals in a country with high coronavirus-related death toll

Miroslaw Kwasniewski, Urszula Korotko, Karolina Chwialkowska, Magdalena Niemira, Jerzy Jaroszewicz, Barbara Sobala-Szczygiel, Beata Puzanowska, Anna Moniuszko-Malinowska, Slawomir Pancewicz, Anna Parfieniuk-Kowerda, Diana Martonik, Dorota Zarebska-Michaluk, Krzysztof Simon, Monika Pazgan-Simon, Iwona Mozer-Lisewska, Maciej Bura, Agnieszka Adamek, Krzysztof Tomasiewicz, Malgorzata Pawlowska, Anna Piekarska, Aleksandra Berkan-Kawinska, Andrzej Horban, Justyna Kowalska, Regina Podlasin, Piotr Wasilewski, Arsalin Azzadin, Miroslaw Czuczwar, Michal Borys, Pawel Piwowarczyk, Slawomir Czaban, Jacek Bogocz, Magdalena Ochab, Anna Kruk, Sandra Uszok, Agnieszka Bielska, Anna Szalkowska, Justyna Raczkowska, Gabriela Sokolowska, Joanna Chorostowska-Wynimko, Aleksandra Jezela-Stanek, Adriana Rozy, Urszula Lechowicz, Urszula Polowianiuk, Agnieszka Tycinska, Kamil Grubczak, Aleksandra Starosz, Wiktoria Izdebska, Tadeusz F. Krzeminski, Jean Bousqet, Genoveffa Franchini, Jennifer Hadlock, Adam Kretowski, Mubeccel Akdis, Cezmi A. Akdis, Milena Sokolowska, Andrzej Eljaszewicz, Robert Flisiak, Marcin Moniuszko

ALLERGY (2023)

Article Immunology

IRAK1 Duplication in MECP2 Duplication Syndrome Does Not Increase Canonical NF-κB-Induced Inflammation

Ilona Gottschalk, Uwe Koelsch, Dimitrios L. Wagner, Jonas Kath, Stefania Martini, Renate Krueger, Anne Puel, Jean-Laurent Casanova, Aleksandra Jezela-Stanek, Rainer Rossi, Salima El Chehadeh, Hilde Van Esch, Horst von Bernuth

Summary: Patients with MECP2/IRAK1 duplication syndrome do not show excessive NF-kappa B signaling, suggesting that therapeutic suppression of this pathway may not benefit these patients.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Review Biochemistry & Molecular Biology

Mucopolysaccharidosis Type 1 among Children-Neuroradiological Perspective Based on Single Centre Experience and Literature Review

Magdalena Machnikowska-Sokolowska, Aleksandra Myszczuk, Emilia Wieszala, Dominika Wieja-Blach, Ewa Jamroz, Justyna Paprocka

Summary: Mucopolysaccharidosis 1 (MPS 1) is a rare lysosomal genetic disorder that causes the accumulation of undegraded glycosaminoglycans (GAGs) in the body, resulting in multiorgan damage. Neurological symptoms can range from mild to severe. Neuroimaging, especially magnetic resonance imaging (MRI), plays a crucial role in diagnosing and monitoring this disease. Early diagnosis is essential for timely therapy implementation. New imaging tools such as MR spectroscopy (MRS), semiquantitative MRI analysis, and scoring systems greatly assist in surveillance of MPS 1. This analysis is based on 5 children with MPS 1 and a review of the literature, highlighting the importance of radiologists' vigilance and knowledge of neuroradiological patterns.

METABOLITES (2023)

Review Biochemistry & Molecular Biology

Ataxia in Neurometabolic Disorders

Konrad Kaminiow, Izabella Rygula, Justyna Paprocka

Summary: There are over 150 inherited metabolic disorders that can present as ataxia in children. Neuroimaging studies and genetic studies are essential for diagnosis. Prompt treatment can positively influence neurodevelopment.

METABOLITES (2023)

Article Biochemistry & Molecular Biology

The Epidermal Transcriptome Analysis of a Novel c.639_642dup LORICRIN Variant-Delineation of the Loricrin Keratoderma Pathology

Katarzyna Wertheim-Tysarowska, Katarzyna Osipowicz, Bartlomiej Gielniewski, Bartosz Wojtas, Alicja Szabelska-Beresewicz, Joanna Zyprych-Walczak, Adriana Mika, Andrzej Tysarowski, Katarzyna Duk, Agnieszka Magdalena Rygiel, Katarzyna Niepokoj, Katarzyna Wozniak, Cezary Kowalewski, Jolanta Wierzba, Aleksandra Jezela-Stanek

Summary: Loricrin keratoderma (LK) is a rare genetic skin disease caused by mutations in the LORICRIN gene. Little is known about the pathogenesis of the disease, and there is limited understanding about the clinical significance of certain gene variants. This study describes two variants in the LORICRIN gene found in two families and provides insight into the gene expression profile and potential therapeutic implications of LK. The results have important implications for genetic counseling and future treatment options.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Pharmacology & Pharmacy

The NMDA receptor antagonists memantine and ketamine as anti-migraine agents

Karolina Podkowa, Kamil Czarnacki, Agnieszka Boronczyk, Michal Boronczyk, Justyna Paprocka

Summary: Migraine, a disorder that affects females more often than males, may be treated with NMDA receptor antagonists such as memantine and ketamine, according to a comprehensive literature review. Animal and in vitro studies have shown that these drugs inhibit the propagation of spreading depression (SD), a major mechanism in migraine pathophysiology. Clinical trials have also indicated that ketamine or memantine may be effective in treating severe migraine, although more studies with control groups are needed. These drugs could be a promising alternative for individuals with treatment-resistant migraine with aura or limited treatment options.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)

Review Genetics & Heredity

Characteristics of Neuroimaging and Behavioural Phenotype in Polish Patients with PIGV-CDG-An Observational Study and Literature Review

Michal Hutny, Patryk Lipinski, Aleksandra Jezela-Stanek

Summary: This study reports the phenotype of six Polish patients with HPMRS1, focusing on behavioral and imaging features that were not addressed in previous reports. Despite having the same PIGV homozygotic mutation, these patients exhibited diverse neurological and developmental disorders, mainly involving muscular tonus and global developmental delay. Behavioral disorders and sensory impairment require additional care and awareness, considering the common global developmental delay observed in these patients.

GENES (2023)

Article Genetics & Heredity

Expanding the Knowledge of KIF1A-Dependent Disorders to a Group of Polish Patients

Justyna Paprocka, Aleksandra Jezela-Stanek, Robert Smigiel, Anna Walczak, Hanna Mierzewska, Anna Kutkowska-Kazmierczak, Rafal Ploski, Ewa Emich-Widera, Barbara Steinborn

Summary: This study analyzed the first Polish patients with confirmed heterozygous pathogenic and potentially pathogenic KIF1A variants. Three novel variants were identified. The authors highlighted the difficulties in classifying particular syndromes due to non-specific and overlapping signs and symptoms, sometimes observed only temporarily.

GENES (2023)

Review Genetics & Heredity

Biochemical, Genetic and Clinical Diagnostic Approaches to Autism-Associated Inherited Metabolic Disorders

Udara D. Senarathne, Neluwa-Liyanage R. Indika, Aleksandra Jezela-Stanek, Elzbieta Ciara, Richard E. Frye, Cliff Chen, Karolina M. Stepien

Summary: Autism spectrum disorders (ASD) are a diverse group of neurodevelopmental disorders characterized by social impairments, communication limitations, and repetitive behaviors. The causes of ASD include genetic, epigenetic, and environmental factors, with a link established between ASD and inherited metabolic disorders (IMDs). This review discusses the biochemical, genetic, and clinical approaches used to investigate IMDs associated with ASD. Biochemical analysis involves examining body fluids to confirm general metabolic or lysosomal storage diseases, while genomic testing technology allows for the identification of specific genetic defects. Early recognition and treatment of IMDs in ASD patients with relevant clinical symptoms and multiorgan involvement can lead to improved care and quality of life.

GENES (2023)

Review Medicine, General & Internal

SERPINA1 and More? A Putative Genetic Contributor to Pulmonary Dysfunction in Alpha-1 Antitrypsin Deficiency

Aleksandra Jezela-Stanek, Joanna Chorostowska-Wynimko

Summary: Alpha-1 antitrypsin deficiency (AATD) is a common inherited disorder that increases the risk of pulmonary disease. The clinical presentation of AATD is highly variable and not strongly linked to genotype and environmental exposure. Genetic factors play a role in the variability of AATD, but their exact role is still unclear. In this review, we summarize the current understanding of epigenetic and genetic modifiers of pulmonary dysfunction in AATD patients.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Genetics & Heredity

Clinical heterogeneity of polish patients with KAT6B-related disorder

Klaniewska Magdalena, Bolanowska-Tyszko Anna, Latos-Bielenska Anna, Jezela-Stanek Aleksandra, Szczaluba Krzysztof, Krajewska-Walasek Malgorzata, Ciara Elzbieta, Pelc Magdalena, Jurkiewicz Dorota, Stawinski Piotr, Zubkiewicz-Kucharska Agnieszka, Rydzanicz Malgorzata, Ploski Rafal, Smigiel Robert

Summary: This article describes a rare genetic disorder called SBBYSS syndrome and its association with the KAT6B gene. The study of six patients revealed a certain degree of phenotypic variability in SBBYSS syndrome. Further research is needed to better understand the range of phenotypes in this disease.

MOLECULAR GENETICS & GENOMIC MEDICINE (2023)

Article Biochemistry & Molecular Biology

Vitamin D Deficiency in Obese Children Is Associated with Some Metabolic Syndrome Components, but Not with Metabolic Syndrome Itself

Jagoda Hofman-Hutna, Michal Hutny, Edyta Matusik, Magdalena Olszanecka-Glinianowicz, Pawel Matusik

Summary: This observational study aimed to assess the nutritional status of vitamin D in obese children and its correlation with metabolic syndrome. The findings suggest that vitamin D deficiency may influence lipid and glucose metabolism in children, leading to the development of abnormalities characteristic of the metabolic syndrome.

METABOLITES (2023)

No Data Available